TO STUDY THE ROLE OF NEBULISATION OF 3% HYPERTONIC SALINE IN THE TREATMENT OF VIRAL BRONCHIOLITIS IN HOSPITALIZED CHILDREN UPTO AGE OF 18 MONTHS

Dr. T. Keerthana, Dr. S. Mohammed Aashiq, Dr. S. Chithra, Dr. Faraaz Adil

Abstract


Background and Objective: In this study we hypothesis that nebulisation with hypertonic  saline is safe, potentially effective treatment reducing the duration of hospital stay in children  with acute Bronchiolitis.The length of  hospital stay observed in our study in children who received additional 3% hypertonic saline nebulisation is less when compared to children who received standard therapy alone. Methods : A Prospective, Randomized controlstudy was conducted  among children who were admitted in Meenakshi Medical College Hospital and Research Institute over a period of 4 months from March to June 2019. They were assessed with RDAI score and SPO2 readings by puloximeter. Patients were randomized to receive treatment either with nebulisation of study solution 3% hypertonic saline along with standard therapy or only standard therapy (i.e oxygen, salbutamol nebulisation, i.v fluids & paracetamol). The clinical response of both the groups were compared and data were analysed.Results : The average reduction in the length of stay observed in our study in the children who received additional 3% hypertonic saline nebulisation is 39 hours when compared with the children who received standard therapy alone.


Keywords


Bronchiolitis , Nebulisation , Respiratory tract infection

Full Text:

PDF

References


American Academy of Pediatrics Subcommittee on diagnosis and management of bronchiolitis Pediatrics 2006;118: 1774-93.

Carlsen KH, Orstavik I, Halvorsen K. Viral infections of the respiratory tract in hospitalized children. Acta Pediatr Scand. 1983; 72:53-54.

Grant SW, Stutman HR, Marks MI. Clinical profile of pediatric patients hospitalized with respiratory syncytial virus infection. Clin Pediatr (Phila). Aug 1993;32(8):450

Hall CB. Respiratory syncytial virus. In Feigen RD, Cherry JC, eds. Textbook of pediatric infectious disease. Philadelphia: WB Saunders, 1992: 1653-1675.

. Henderson FW, Clyde WA Jr, Collier AM, et al. The etiologic and epidemiologic spectrum of bronchiolitis in pediatric practice. J Pediatr. Aug 1979;95(2):183-90

, Henrickson KJ, Hoover S, Kehl KS, Hua W: National disease burden of respiratory viruses detected in children by polymerase chain reaction. Pediatr Infect Dis J 2004, 23:S11-8

Koehoorn M, Karr CJ, Demers PA, Lencar C, Tamburic L, Brauer M. Descriptive epidemiological features of bronchiolitis in a population-based cohort. Pediatrics. Dec 2008;122(6):1196-203

Kuzik BA, Al Qadhi SA, Kent S, Flavin MP, Hopman W, Hotte S, Gander S. Nebulized hypertonic saline in the treatment of viral bronchiolitis in infants. J Pediatr 2007;151:266-70

Law BJ, Carbonell-Estrany X, Simoes EA. An update on respiratory syncytial virus epidemiology: a deve loped country perspective. Respir Med. 2002;96

Mandelberg A, Tal G, Witzling M, Someck E, Houri S, Balin A, et al.Nebulized 3%hypertonic saline solution treatment in hospitalized infants with viral bronchiolitis. Chest 2003;123:481–7.

Rudan I, Tomaskovic L, Boschi-Pinto C, Campbell H. Global estimate of the incidence of clinical pneumo nia among children under five years of age. Bull World Health Organ. Dec 2004; 82(12):895-903.


Refbacks

  • There are currently no refbacks.